Speed of tPA-Induced Clot Lysis Predicts DWI Lesion Evolution in Acute Stroke

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Stroke

• Publication date

  2007-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.STR.0000257977.32525.6ePMID 17290028
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Temporal Profile of Recanalization After Intravenous Tissue Plasminogen Activator: Selecting Patients for Rescue Reperfusion Techniques

  2006cited by this paper
• Enhancing the Development and Approval of Acute Stroke Therapies: Stroke Therapy Academic Industry Roundtable

  2005cited by this paper
• Evolution of lesion volume in acute stroke treated by intravenous t‐PA

  2005cited by this paper
• Predictors of Apparent Diffusion Coefficient Normalization in Stroke Patients

  2004cited by this paper
• Differential Pattern of Tissue Plasminogen Activator–Induced Proximal Middle Cerebral Artery Recanalization Among Stroke Subtypes

  2004cited by this paper
• Beyond Mismatch: Evolving Paradigms in Imaging the Ischemic Penumbra With Multimodal Magnetic Resonance Imaging

  2003cited by this paper
• Improving the Predictive Accuracy of Recanalization on Stroke Outcome in Patients Treated With Tissue Plasminogen Activator

  2003cited by this paper
• Serial magnetic resonance imaging in experimental primate stroke: Validation of MRI for pre-clinical cerebroprotective trials

  2003cited by this paper
• Thrombolysis in stroke beyond three hours: Targeting patients with diffusion and perfusion MRI

  2002cited by this paper
• Prediction of Early Neurological Deterioration Using Diffusion- and Perfusion-Weighted Imaging in Hyperacute Middle Cerebral Artery Ischemic Stroke

  2002cited by this paper
• Use of diffusion and perfusion magnetic resonance imaging as a tool in acute stroke clinical trials

  2001cited by this paper
• Speed of Intracranial Clot Lysis With Intravenous Tissue Plasminogen Activator Therapy: Sonographic Classification and Short-Term Improvement

  2001cited by this paper
• Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging

  2000cited by this paper
• Transcranial doppler ultrasound criteria for recanalization after thrombolysis for middle cerebral artery stroke.

  2000cited by this paper
• Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators.

  2000cited by this paper
• Effect of citicoline on ischemic lesions as measured by diffusion‐weighted magnetic resonance imaging

  2000cited by this paper
• Transport Processes in Fibrinolysis and Fibrinolytic Therapy

  1996cited by this paper
• Tissue plasminogen activator for acute ischemic stroke.

  1996cited by this paper
• Tissue plasminogen activator for acute ischemic stroke.

  1995cited by this paper
• Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.

  1995cited by this paper
• Improved Reliability of the NIH Stroke Scale Using Video Training

  1994cited by this paper
• Interobserver agreement for the assessment of handicap in stroke patients.

  1989cited by this paper
• Interobserver agreement for the assessment of handicap in stroke patients.

  1988cited by this paper

• Regulatory T cells in stroke inflammation: Therapeutic perspectives.

  2025cites this paper
• The different clinical value of susceptibility vessel sign in acute ischemic stroke patients under different interventional therapy: A systematic review and meta-analysis.

  2019cites this paper
• ImagIng In acute Stroke – new optIonS and State of the art

  2018cites this paper
• Transcranial diffuse optical assessment of the microvascular reperfusion after thrombolysis for acute ischemic stroke

  2018cites this paper
• Anti-inflammatory treatments for stroke: from bench to bedside

  2018cites this paper
• Transcranial diffuse optical assessment of the microvascular reperfusion after thrombolysis for acute ischemic stroke.

  2018cites this paper
• Modulation by the Noble Gas Helium of Tissue Plasminogen Activator: Effects in a Rat Model of Thromboembolic Stroke*

  2016cites this paper
• Meta-analysis of Vascular Imaging Features to Predict Outcome Following Intravenous rtPA for Acute Ischemic Stroke

  2016cites this paper
• Factors Associated with Thrombolysis Outcome in Ischemic Stroke Patients with Atrial Fibrillation

  2016cites this paper
• Subjects and methods

  2016cites this paper
• Letter by Gauberti and Vivien regarding article, "amplification of regulatory T cells using a CD28 superagonist reduces brain damage after ischemic stroke in mice".

  2015cites this paper
• Recovery Potential After Acute Stroke

  2015cites this paper
• Lack of secondary microthrombosis after thrombin‐induced stroke in mice and non‐human primates

  2014cites this paper
• Incidence, causes and predictors of neurological deterioration occurring within 24 h following acute ischaemic stroke: a systematic review with pathophysiological implications

  2014cites this paper
• Pharmacokinetics of alteplase in the treatment of ischaemic stroke

  2012cites this paper
• Early infarct growth predicts long-term clinical outcome after thrombolysis.

  2012cites this paper
• Outcome after systemic thrombolysis is predicted by age and stroke severity: an open label experience with recombinant tissue plasminogen activator and tirofiban

  2012cites this paper
• Administration of edaravone, a free radical scavenger, during t-PA infusion can enhance early recanalization in acute stroke patients--a preliminary study.

  2012cites this paper
• The hemodynamic status within 24 h after intravenous thrombolysis predicts infarct growth in acute ischemic stroke

  2012cites this paper
• Factors and Outcomes Associated with Recanalization Timing after Thrombolysis

  2012cites this paper
• Oxygen challenge MRI: development of a novel technique and application to acute stroke patients

  2012cites this paper
• Neurosonological Evaluation of the Acute Stroke Patients

  2011cites this paper
• Impact of Tissue Plasminogen Activator on the Neurovascular Unit: From Clinical Data to Experimental Evidence

  2011cites this paper
• Clinical and MRI Predictors of No Early Recanalization Within 1 Hour After Tissue-Type Plasminogen Activator Administration

  2011cites this paper
• Simultaneous Combined Intravenous Recombinant Tissue Plasminogen Activator and Endovascular Therapy for Hyperacute Middle Cerebral Artery M1 Occlusion

  2011cites this paper
• Metabolic reflow as a therapy for ischemic brain injury.

  2011cites this paper
• Interactions between Nitrous Oxide and Tissue Plasminogen Activator in a Rat Model of Thromboembolic Stroke

  2011cites this paper
• Endovascular Therapies for Cerebral Revascularization

  2011cites this paper
• Neuroimaging for Clinicians - Combining Research and Practice

  2011cites this paper
• Failed Recovery from Thrombolysis Is Predicted by the Initial Diffusion Weighted Imaging Lesion

  2011cites this paper
• Intravenous Tissue Plasminogen Activator Thrombolysis in Patients without Major Arterial Occlusion Seems to Be Safe and Effective

  2010cites this paper
• Human Recombinant Tissue-Plasminogen Activator (Alteplase): Why Not Use the ‘Human’ Dose for Stroke Studies in Rats?

  2010cites this paper
• Role of neuroimaging in promoting long‐term recovery from ischemic stroke

  2010cites this paper
• Xenon is an Inhibitor of Tissue-Plasminogen Activator: Adverse and Beneficial Effects in a Rat Model of Thromboembolic Stroke

  2010influential citation
• IV t-PA therapy in acute stroke patients with atrial fibrillation.

  2009cites this paper
• Emergent endovascular arterial reconstruction for intravenous t-PA unresponsive acute stroke patients

  2009cites this paper
• Expediting MRI-Based Proof-of-Concept Stroke Trials Using an Earlier Imaging End Point

  2009cites this paper
• Recanalization of the MCA should play an important role in dramatic recovery after t-PA therapy in patients with ICA occlusion.

  2009cites this paper
• Does Diffusion-Weighted Imaging Represent the Ischemic Core? An Evidence-Based Systematic Review

  2009cites this paper
• Expediting MRI-Based Proof-of-Concept Stroke Trials Using an Earlier Imaging End

  2009cites this paper
• MRI-Based Selection for Intra-Arterial Stroke Therapy: Value of Pretreatment Diffusion-Weighted Imaging Lesion Volume in Selecting Patients With Acute Stroke Who Will Benefit From Early Recanalization

  2009cites this paper
• Safer thrombolysis for acute ischemic stroke

  2008cites this paper
• Hemorrhagic transformation of ischemic brain tissue after t-PA thrombolysis as detected by MRI may be asymptomatic, but impair neurological recovery.

  2008cites this paper
• Establishing Final Infarct Volume: Stroke Lesion Evolution Past 30 Days Is Insignificant

  2008cites this paper
• Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients.

  2008cites this paper
• [IV t-pA thrombolysis in acute stroke patients].

  2008cites this paper
• Atrial fibrillation as an independent predictor for no early recanalization after IV-t-PA in acute ischemic stroke.

  2008cites this paper
• Transcranial Ultrasound in Acute Stroke: From Diagnosis to Therapy

  2007cites this paper
• Monitoring and imaging the clot during systemic thrombolysis in stroke patients

  2007cites this paper
• Better late than never?

  2007cites this paper